研究论文

三唑类白杨素衍生物的设计、合成及其抗增殖活性研究

  • 栾天 ,
  • 全哲山 ,
  • 方应权 ,
  • 杨宏静
展开
  • a 重庆三峡医药高等专科学校药学院 重庆 404120;
    b 延边大学药学院 吉林延吉 133002;
    c 沈阳医学院药学院 沈阳 110034

收稿日期: 2019-07-05

  修回日期: 2019-07-23

  网络出版日期: 2019-10-12

基金资助

国家自然科学基金(No.21662036)资助项目.

Design, Synthesis and Antiproliferative Activity of Chrysin Derivatives Bearing Triazole Moieties

  • Luan Tian ,
  • Quan Zheshan ,
  • Fang Yingquan ,
  • Yang Hongjing
Expand
  • a Department of Pharmacy, Chongqing Three Gorges Medical College, Chongqing 404120;
    b College of Pharmacy, Yanbian University, Yanji, Jilin 133002;
    c College of Pharmacy, Shenyang Medical College, Shenyang 110034

Received date: 2019-07-05

  Revised date: 2019-07-23

  Online published: 2019-10-12

Supported by

Project supported by the National Natural Science Foundation of China (No. 21662036).

摘要

合成了2个系列的白杨素衍生物,采用噻唑蓝(MTT)法测试了所有化合物针对六种肿瘤细胞的体外抗增殖活性,包括MGC-803,BEL-7402,HepG2,HeLa,A549以及SGC-7901细胞.实验结果显示,7-[1-(3-氟苯基)-1H-1,2,3-三唑-4-甲氧基]-白杨素(1c)与7-[1-(2-氯苯基)-1H-1,2,3-三唑-4-甲氧基]-白杨素(1g)针对MGC-803细胞的活性与先导化合物白杨素及阳性对照药5-氟尿嘧啶相比显著提高.因此,化合物1c1g具有深入研究用以开发抗癌药物的潜能.

本文引用格式

栾天 , 全哲山 , 方应权 , 杨宏静 . 三唑类白杨素衍生物的设计、合成及其抗增殖活性研究[J]. 有机化学, 2020 , 40(2) : 440 -446 . DOI: 10.6023/cjoc201907012

Abstract

Two series of novel chrysin derivatives were synthesized, and their antiproliferative activity was evaluated against six human cancer cell lines (MGC-803, BEL-7402, HepG2, HeLa, A549, and SGC-7901) using methyl thiazolyl tetrazolium (MTT) assay. Preliminary bioassay results indicated that 7-((1-(3-fluorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one (1c) and 7-((1-(2-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-5-hydroxy-2-phenyl-4H-chro-men-4-one (1g) exhibited significantly improved antiproliferative activities against the MGC-803 cell line when compared with the parent compound chrysin and the positive control drug 5-fluorouracil. It demonstrates that compounds 1c and 1g are potential agents for cancer therapy.

参考文献

[1] Chen, Y. H.; Yang, Z. S.; Wen, C. C.; Chang, Y. S.; Wang, B. C.; Hsiao, C. A.; Shih, T. L. Food Chem. 2012, 134, 717.
[2] Critchfield, J. W.; Butera, S. T.; Folks, T. M. AIDS Res. Hum. Retroviruses 1996, 12, 39.
[3] Du, Q.; Gu, X.; Cai, J.; Huang, M.; Su, M. Mol. Med. Rep. 2012, 6, 100.
[4] Gresa-Arribas, N.; Serratosa, J.; Saura, J.; Solã, C. J. Neurochem. 2010, 115, 526.
[5] Brown, E.; Hurd, N. S.; McCall, S.; Ceremuga, T. E. AANA J. 2007, 75, 333.
[6] Khoo, B. Y.; Chua, S. L.; Balaram, P. Int. J. Mol. Sci. 2010, 11, 2188.
[7] Prabhakar, M. M.; Manoharan, S.; Baskaran, N.; Srinivasan, R.; Karthikeyan, S.; Wani, S. A. Int. J. Phram. Sci. 2012, 3, 89.
[8] Srinivasan, R.; Manoharan, S. J. Cell Tissue Res. 2011, 11, 2909.
[9] Yu, X. M.; Phan, T.; Patel, P. N.; Jaskula-Sztul, R.; Chen, H. Cancer 2013, 119, 774.
[10] Tsuji, P. A.; Winn, R. N.; Walle, T. Chem. Biol. Interact. 2006, 164, 85.
[11] Walle, U. K.; Galijatovic, A.; Walle, T. Biochem. Pharmacol. 1999, 58, 431.
[12] Dos Anjos, J. V.; Sinou, D.; De Melo, S. J.; Srivastava, R. M. Carbohydr. Res. 2007, 342, 2440.
[13] Luan, T.; Cao, L. H.; Deng, H.; Shen, Q. K.; Tian, Y. S.; Quan, Z. S. Molecules 2019, 24, 121.
[14] Liu, C. F.; Shen, Q. K.; Li, J. J.; Tian, Y. S.; Quan, Z. S. J. Enzym. Inhib. Med. Chem. 2017, 32, 1111.
[15] Hu, K.; Wang, W.; Cheng, H.; Pan, S. S.; Ren, J. Med. Chem. Res. 2011, 20, 838.
[16] Liu, J. W.; Taylor, S. F.; Dupart, P. S.; Arnold, C. L.; Sridhar, J.; Jiang, Q.; Wang, Y.; Skripnikova, E. V.; Zhao, M.; Foroozesh, M. J. Med. Chem. 2013, 56, 4082.
[17] Maingot, L.; Elbakali, J.; Dumont, J.; Bosc, D.; Cousaert, N.; Urban, A.; Deglane G.; Villoutreix, B.; Nagase, H.; Sperandio, O.; Leroux, F.; Deprez, B.; Deprez-Poulain, R. Eur. J. Med. Chem. 2013, 69, 244.
[18] Zou, X. Q.; Peng, S. M.; Hu, C. P.; Tan, L. F.; Yuan, Q.; Deng, H. W.; Li, Y. J. Bioorg. Med. Chem. 2010, 18, 3020.
文章导航

/